Endoscopic retrograde cholangiopancreatography (ERCP) is an essential procedure that can be complicated by post-ERCP pancreatitis (PEP). Indomethacin and ketorolac are two medications used to prevent PEP. The main reason for this research study is to compare the effectiveness these drugs at reducing rates of PEP. There have been no studies comparing the effectiveness of these medications in preventing PEP in pediatric patients. You are being asked to take part in this research study because you are scheduled to have an ERCP as part of your medical care.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Post-ERCP Pancreatitis
Timeframe: 2 weeks
Post-ERCP Pancreatitis: Pancreatic Duct Injections
Timeframe: 2 weeks
Post-ERCP Pancreatitis: Native Papilla
Timeframe: 2 weeks
Post-ERCP Pancreatitis: Pancreatic Sphincterotomy
Timeframe: 2 weeks
Post-ERCP Pancreatitis: Opti-Ray Amount
Timeframe: 2 weeks
Post-ERCP Pancreatitis: Therapeutic Pancreatic Duct Stent Placed
Timeframe: 2 weeks
Post-ERCP Pancreatitis: Prophylactic Pancreatic Duct Stent Placed
Timeframe: 2 weeks